AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
A Novel Class of Exceptionally Potent HIV-1 Protease Inhibitors
Summary
Researchers at Purdue University have synthesized a series of exceptionally potent inhibitors for HIV-1 protease, which have been documented as an effective strategy for the treatment of AIDS and HIV. These compounds represent a novel class of HIV-1 protease inhibitors, which have proven to be up to 20-fold more potent than other protease inhibitors on the market.
Technology Benefits
Far more potent than other protease inhibitors on the marketGreater potency will significantly reduce dosage requirements Treatment of multidrug-resistant strain of HIV
Technology Application
Medical/HealthcareHIV/AIDS Treatment
Detailed Technology Description
Arun GhoshGhosh GroupPurdue Chemistry
Countries
United States
Application No.
9,024,038
Country/Region
USA
For more information, please click Here
